ABSTRACT Background: Evidence suggests that in women with a normal to high body mass index (BMI; in kg/m 2 ), the extra amino acids needed during pregnancy are met through reduced oxidation. It is not known whether a woman with a low BMI can make this adaptation successfully. Objective: The objective was to measure and compare leucine kinetic parameters and alanine-nitrogen, glutamine amide-nitrogen, and glycine and cysteine fluxes in Indian women with a low and normal BMI in early and midpregnancy. in the first and second trimesters of pregnancy. Results: Leucine, glutamine, glycine, and cysteine fluxes were faster in women with a low BMI in both trimesters, but there was no difference in alanine flux between groups. This difference was explained in the first trimester by a higher proportion of fat-free mass in low-BMI women. Leucine oxidation and percentage of dietary leucine oxidized were higher in low-BMI women in both trimesters, but nonoxidative disposal was not different between groups. Conclusions: Although they use dietary protein less efficiently, low-BMI women maintain net protein synthesis at the same rate as do normal-BMI women and produce similar quantities of labile nitrogen for the de novo synthesis of other dispensable amino acids such as glycine and cysteine. The extra amino acids required for increased maternal protein synthesis during pregnancy are provided by an overall decrease in amino acid catabolism in women with normal or low BMI.
INTRODUCTION
The prevalence of low birth weight (LBW) is high in Indian infants (1) and is a significant contributor to neonatal morbidity and mortality (2) . Most LBW infants in India and in most developing countries are a result of intrauterine growth retardation and a compromised maternal nutritional status (3, 4) . Evidence that short teenage mothers with lower body weights and body mass indexes (BMIs; in kg/m 2 ) have lighter placentas and smaller infants (5) suggests that underweight mothers are not capable of providing adequate nutrients, especially energy and protein, for growth of the reproductive tissues and the fetus. However, the metabolic mechanisms linking maternal weight and fetal growth are not fully understood.
Some consistent findings are that protein synthesis is higher in healthy pregnant women in the second and third trimesters than in the first trimester (6) and that urea production and excretion are higher in healthy pregnant women than in nonpregnant women (7) (8) (9) . These findings, together with an almost identical pattern of change in leucine transamination (7) , suggest that the extra amino acids required for increased maternal protein synthesis are provided by an overall decrease in amino acid catabolism. However, with potentially low protein stores, as can be assumed from earlier studies in Indians with a low BMI who had lower ratios of muscle mass to viscera in their fat-free mass (10), it is not known whether pregnant women with a low BMI can make these adaptations successfully.
Furthermore, for the same reasons, it is also possible that the availability of the dispensable amino acids will be compromised in pregnant woman with a low BMI if there is insufficient labile amino nitrogen to support their de novo synthesis. The dispensable amino acids have an important role in intermediary metabolism: for example, besides being a neurotransmitter and a one-carbon donor, glycine is a precursor for the formation of purines, porphyrins, creatine, glutathione, and, through its interconversion to serine, phospholipids, and cysteine (11) . Cysteine is the rate-limiting precursor for synthesis of glutathione (12) , the primary intracellular antioxidant. Alanine and glutamine, as primary carriers of nitrogen in the body, play pivotal roles linking amino acid, glucose, and protein metabolism, and their fluxes would reflect the availability of labile nitrogen for de novo amino acid synthesis.
Because pregnant women with a low BMI may have low protein stores, the present study aimed first to determine whether protein (represented by leucine) turnover and catabolism rates were lower in these women than in women with a normal BMI during pregnancy and, second, to test the hypothesis that in the fasted state, pregnant women with low BMI would have slower fluxes of glutamine amide-nitrogen and alanine-nitrogen, which indicates the decreased availability of labile nitrogen for the de novo synthesis of other dispensable amino acids such as glycine and cysteine. Therefore, leucine kinetics and the fluxes of cysteine, glycine, the amide-nitrogen moiety of glutamine, and the amino-nitrogen moiety of alanine were measured in the first 2 trimesters of pregnancy in pregnant women with a low BMI ( 18.5) or a normal BMI (.18.5 and 25.0) in the fasted and fed states.
SUBJECTS AND METHODS
The study was conducted from December 2006 
Subjects
Pregnant women at ,13 wk of gestation were eligible for the study. Women with multiple pregnancies, those with a clinical diagnosis of chronic illness (eg, diabetes mellitus, hypertension, heart disease, thyroid disease, and epilepsy), and those who tested positive for hepatitis B surface antigen, HIV, or syphilis were excluded. Twenty subjects, 10 with a low BMI (BMI 18.5) and 10 with a normal BMI (BMI . 18.5 and 25.0) were enrolled for the study after screening. Two subjects were excluded during the course of study; one because of an abortion at 14 wk and the other because of signs of epilepsy at 20 wk of gestation. At recruitment, routine antenatal tests were carried out. Folic acid, iron, and calcium supplements and tetanus toxoid were given as routine antenatal care.
Anthropometric measures and habitual food intakes
At recruitment, the age and obstetric history were recorded for each subject. Gestational age was assessed from the last menstrual period and confirmed by ultrasound within 2 wk of the initial visit. Maternal weight and height were recorded to the nearest 0.1 kg and 0.1 cm just before each tracer experiment. Gestational weight gain (GWG) was calculated per week between measurements. Mid-upper arm circumference was measured to the nearest 0.1 cm, and skinfold thicknesses were measured at 3 sites (biceps, triceps, and subscapular) to the nearest 0.2 mm by using skinfold calipers (Holtain, Crymych, United Kingdom). The skinfold-thickness measurement was used for the prediction of body density by using prediction equations (13) , from which the percentage body fat was estimated in the first trimester (14) . At birth, the infants were measured to the nearest 0.01 kg on a standard beam scale balance. LBW was defined as birth weight ,2.5 kg, and intrauterine growth retardation was defined as a birth weight below the 10th percentile for the gestational age (15) .
A food-frequency questionnaire was administered at each trimester visit to obtain information on the habitual dietary intake for the preceding 3 mo. The food-frequency questionnaire was adapted from that developed for the urban middle class residing in South India (16) and was validated against 24-h food recalls that were obtained thrice during each trimester of pregnancy in 100 subjects. For energy intakes, the correlation between the methods was significant at all trimesters (r = 0.4, 0.5, and 0.5 in first, second, and third trimesters, respectively; P , 0.001).
Tracer-infusion protocol
The tracer-infusion protocol consisted of 2 parts: a fasted state of 4 h and a fed state of 5 h. In the fed state, the subjects were given small hourly meals, which provided 1/12th of their habitual daily protein and energy, based on 1.35 times their basal metabolic rate. The meals were made with a powdered dietary supplement (Ensure; Abbott Health Care Private Ltd, Mumbai, India), skimmed milk powder, beet sugar, bread, and butter. The meals consisted of 65% carbohydrate, 15% protein, and 20% fat and provided '65 lmol leucine Á kg 21 Á h
21
. The actual dietary intake of each amino acid was calculated by using food-composition tables and the manufacturer's published composition. For the low-BMI group, in the first and second studies, the meals provided a mean (6SE) of 11.1 6 0.6 and 12.6 6 0.7 lmol cysteine Á kg 21 All subjects were studied on 2 occasions, at the end of the first (12 6 1 wk of gestation) and second (24 6 1 wk of gestation) trimesters. The women were not willing to come in for an assessment in the third trimester; therefore, this time point was not studied. Subjects were admitted to the obstetrics ward in the evening and finished dinner based on their habitual diet before 1900. About 3 h later, an intravenous catheter (Jelco, 22G; Medex Medical Ltd, Lancashire, United Kingdom) was inserted into the antecubital vein of one arm for the infusion of isotopes, whereas another catheter was inserted into the dorsal vein of the contralateral hand for drawing blood samples and kept patent with a slow saline drip. A warm blanket around the hand, maintained at 60-65°C, was used to arterialize the venous blood collected; the extent of arterialization was assessed by measuring hemoglobin saturation in a test sample; this was usually .95%. lmol Á kg 21 Á h 21 ) were also started. The bicarbonate pool was also primed with 0.5 lmol NaH 13 CO 3 /kg at the start. After a 4-h isotope infusion (the fasted state), the subjects were given small hourly meals for the remaining 5 h (fed state), and the enrichments of different tracers at the end of each metabolic period are presented in Figure 1 . This pattern of early feeding was necessary because all of the women did not want to spend the additional next day in the obstetrics ward and wished to return home in the morning, because they had families to care for. In addition, although there are distinct circadian patterns of hormone secretion, human studies have shown no circadian effect on energy expenditure and protein oxidation (17) and that the overriding regulatory influence on protein utilization is the availability of amino acids, rather than insulin (18) . Blood and breath samples were collected at 10-min intervals during the last 0.5 h of the fasted and fed states. Total carbon dioxide excretion was determined with an open-circuit indirect calorimeter (MetaMax, Cortex, Germany) during the last hour of the fasted and fed states. At the end of the infusion, the subjects were given breakfast and discharged.
Laboratory analyses
Blood samples were drawn into 5-mL syringes and transferred into EDTA-coated anticoagulant tubes and centrifuged at 4°C for 15 min at 1200 · g. Plasma was removed and stored at 280°C. The breath samples were analyzed for 13 C abundance in carbon dioxide by gas-isotope-ratio mass spectrometry (Europa Scientific, Crewe, United Kingdom), with monitoring ions at m/z ratios of 44 and 45. Plasma amino acid concentrations were measured by reversed-phase HPLC on a Hewlett-Packard 1090 HPLC equipped with a model HP 1046A fluorescence detector (Hewlett-Packard, Avondale, PA). Plasma a-keto-isocaproic acid (aKICA) isotopic enrichment was measured by negative chemical ionization gas chromatography-mass spectrometric analysis of its pentafluorobenzyl derivative by selectively monitoring ions at m/z 129-130. Plasma amino acids were isolated by ionexchange (Dowex 200·) chromatography, and their isotopic enrichments were determined by negative chemical ionization gas chromatography-mass spectrometric analysis of their heptafluorobutyramide derivative. Dithiothreitol, 0.075 mL of a 10-mmol/L solution, was added to the derivatization mixture to convert cystine to cysteine. Ions were selectively monitored at m/z ratios of 535-537 for cysteine, 293-295 for glycine, 307-308 for alanine, and 346-347 for glutamine. In all these assays, a Hewlett-Packard 5890 quadrupole mass spectrometer (Hewlett-Packard, Palo Alto, CA) was used.
Calculations
Total amino acid flux (Q) was calculated as follows:
where Tr/Tr inf is the tracer/tracee ratio of the infusate, I is the tracer infusion rate (lmol Á kg 21 Á h
21
), and Tr/Tr pl is the tracer/ tracee ratio of aKICA, cysteine, glycine, alanine, or glutamine in plasma.
Endogenous amino acid flux was only calculated in the fasted state (Q endofast ), ie, amino acids derived from protein breakdown and de novo synthesis (in the case of dispensable amino acids) were calculated as the difference between total amino acid flux and intravenous tracer amino acid intake. For example, endogenous fasted leucine flux is calculated as follows:
In the case of leucine, the following terms were additionally calculated. Leucine oxidation (Leu oxd ), an index of protein catabolism, was calculated as follows:
where VCO 2 is the rate of carbon dioxide excretion in the breath, 0.78 adjusts for the fraction of carbon dioxide produced that is recovered in expired air, E CO2 is the plateau isotopic enrichment of breath carbon dioxide, and E paKICA is the plasma isotopic enrichment of aKICA. Nonoxidative leucine disposal (NOLD), that is, leucine used for protein synthesis, was calculated as Q minus leucine oxidation (Leu oxd ). Leucine balance (Leu bal ), an index of net protein synthesis (fed state) or loss (fasted state), was calculated as the difference between leucine intake and leucine oxidation. For example, in the fed state
The percentage of dietary leucine intake oxidized was calculated as follows:
Leu oxd =ðdietleucine þ intravenous½ 13 CleucineÞ 2 100 ð5Þ
Statistical methods
The data are presented as arithmetic means 6 SD, unless otherwise specified. The anthropometric and dietary intake variables were analyzed between groups by using an independent Students t test and between trimesters by using a paired Student's t test. The metabolic variables were analyzed by using mixed-models analysis of variance. This model, for amino acid flux, or leucine oxidation, NOLD, and balance, included the group (low and normal BMIs), metabolic phase (fasted and fed state), trimester (first and second), and all interactions between the 3 factors with metabolic phase and trimester considered as repeated factors. Post hoc comparisons were performed for significant interactions by using Tukey's test. The kinetics data were normalized for weight because the 2 groups were significantly different in weight and because the weight-specific data could be compared with earlier data from the literature. Additionally, whole-body data (using weight as a covariate) as well as FFM-specific values (except for trimesterbased effects, because FFM was not estimated in the second trimester) were analyzed by using the same model, because body weights were significantly different between the groups. For percentage dietary leucine oxidized (which was only measured in the fed state), the same mixed model was used without metabolic phase. Bivariate correlations between birth weight or All values are means 6 SDs. Data were analyzed by using an independent t test for comparisons of the low-and normal-BMI groups in the same trimester. There were no significant differences between the first and second trimesters within groups. 2, 3 Significantly different from the same trimester in the normal-BMI group (independent t test): GWG and leucine kinetic variables were examined for the entire data set by using Pearson's correlation coefficient. Two-sided P values of 0.05 indicated significance for tests of interactions and main effects. The data were analyzed by using the PROC MIXED module in SAS version 9.1.3 (SAS Institute Inc, Cary, NC).
RESULTS

Anthropometric measures and dietary intakes
The mean anthropometric indexes of the subjects are summarized in Table 1 . There were no differences between the groups in their habitual physical activity level, weekly GWG, or birth weight of the infants. The habitual dietary intakes of the subjects in both trimesters are summarized in Table 2 . In general, the body weight-normalized macronutrient intakes of the low-BMI group were significantly higher than those of the normal-BMI group. However, there were no significant changes in intakes from the first to the second trimester for either group. The protein:energy ratio of the diet was between 11% and 12% for both groups in both trimesters. The low-BMI group had a higher leucine intake because of its generally higher cereal and protein intakes.
Leucine kinetics
Plasma leucine concentrations did not change from the first to the second trimesters, were not significantly different between groups, but were significantly lower in the fasted state than in the fed state (P = 0.0004; Table 3 ). Leucine flux was lower in the normal-BMI group (P = 0.004) and, with regard to metabolic state, was higher in the fed state (P , 0.0001). In addition, there was a significant interaction effect between trimester and BMI group (P = 0.023), such that in the low-BMI group in the first trimester, leucine flux (in both fasted and fed state) was significantly higher (P = 0.009) than in the normal-BMI group. The percentage changes in leucine flux between trimesters in the fasted and fed states were 11% and 7% in the normal-BMI group and 0% and 23% in the low-BMI group, respectively. Endogenous fasted leucine flux followed similar trends. The percentage change in fasted endogenous leucine flux between trimesters was 12% in the normal-BMI group, whereas it was 1% in the low-BMI group ( Table 4) . Across trimesters and BMI groups, leucine oxidation was higher in the fed state (P , 0.0001). There was a significant interaction effect between metabolic phase and BMI group (P = 0.0196), such that leucine oxidation was significantly lower in the normal-BMI group (P = 0.04) than in the low-BMI group in the fed state. The percentage leucine intake that was oxidized was lower in the second trimester by '34% and 32% than in the first trimester in the normal-and low-BMI groups, respectively; therefore, the efficiency of protein utilization increased significantly in the second trimester. With respect to NOLD, there was a significant increase in the second trimester (P = 0.029), and, although the group interaction was not significant, the increase in NOLD from the first to the second trimester tended to be greater in the normal-BMI group. Leucine balance increased significantly across trimesters in both groups (P = 0.003) and was higher in the fed state (P , 0.0001). When whole-body data (using weight as a covariate) were analyzed, the BMI group-based differences in leucine kinetic parameters disappeared; however, all the trimesterbased (first compared with second trimesters) and metabolic state (fasted compared with fed) differences persisted. Similar findings occurred when FFM-specific data were analyzed in the first trimester (Table 4) . Statistically significant correlations between leucine kinetic parameters, such as oxidation, NOLD, and flux in the first trimester and birth weight and maternal weekly GWG are shown in Table 5 .
Alanine-nitrogen and glutamine amide-nitrogen kinetics
Alanine and glutamine flux were significantly higher in the fed state than in the fasted state (P , 0.0001 and P = 0.005, respectively; Table 6 ), whereas glutamine flux was higher in the low-BMI group (P = 0.0005), specifically, in the first trimester (P = 0.003). In addition, in the low-BMI group, glutamine flux in the first trimester was significantly higher than in the second trimester (in both the fasted and fed states; P = 0.013). Similar differences existed for both fasted alanine and glutamine endogenous flux. When whole-body flux rates were examined with weight as a covariate, glutamine flux remained higher (P = 0.002) in the second trimester. FFM-specific glutamine flux was higher in the low-BMI group (P = 0.04) in the first trimester ( Table 6 ). The difference in metabolic state also remained significantly higher in the fed state for both alanine and glutamine. Plasma alanine concentrations were significantly higher in the fed state than in the fasted state (P = 0.007), but there were no differences between groups or trimesters. There were also no significant differences in glutamine concentrations between groups, trimesters, or metabolic state (Table 3) .
Cysteine and glycine kinetics
Cysteine flux rates were higher in the low-BMI group (P = 0.02) in the second trimester (P = 0.01) and in the fasted state (P , 0.0001). For glycine flux, the main effects of BMI and trimester were significant ( Table 7) . Glycine flux in the low-BMI group was higher (P = 0.01) and first trimester was higher (P = 0.01). The endogenous fasted glycine flux showed similar differences as the total fasted glycine flux. When whole-body flux rates were examined with weight as a covariate or with FFM-specific data in the first trimester (Table 7) , the effect of metabolic state remained significant for both cysteine (P , 0.001) and glycine (P = 0.005). In addition, whole-body cysteine flux was higher in the normal-BMI group (P = 0.046) and in the second trimester (P , 0.001). Plasma glycine concentrations did not change from 1 All values are means 6 SDs. Fat-free mass (FFM)-specific leucine kinetics are presented only for the first trimester, because this measurement was only available for the first trimester. NOLD, nonoxidative leucine disposal. Data were analyzed by using mixed-model ANOVA.
2 Significant main effect of metabolic phase (fasted compared with fed, P , 0.0001) and BMI (low BMI compared with normal BMI, P , 0.05) but no main effect of trimester. Significant interaction effect between trimester and BMI group (P , 0.05); total leucine flux in first trimester was significantly lower in the normal-BMI than in the low-BMI group (P , 0.05); other 2-factor and 3-factor interactions were not significant. 3 Significant main effect of metabolic phase (fasted compared with fed, P , 0.001) but no main effect of BMI. 4 Significant main effect of BMI (low BMI compared with normal BMI, P , 0.05) but no main effect of trimester. Significant interaction effect between trimester and BMI group (P , 0.05); fasted endogenous flux in first trimester was significantly lower in the normal-BMI than in the low-BMI group (P , 0.05).
5 Significant main effect of metabolic phase (fasted compared with fed, P , 0.0001), but main effects of trimester and BMI were not significant. Significant interaction effect between metabolic phase and BMI group (P , 0.05): leucine oxidation in the fed phase was significantly lower in the normal-BMI than in the low-BMI group (P , 0.05); other 2-factor and 3-factor interactions were not significant. 6 Measured for per kg body weight data only. Significant main effect of metabolic phase (fasted compared with fed, P , 0.0001) and trimester (first compared with second trimester, P , 0.05) but no main effects of BMI and interaction effects.
7 Measured for per kg body weight data only. Significant effect of trimester (first compared with second trimester, P , 0.005) but no main effect of BMI or interaction effects. 8 Significant effect of trimester (first trimester compared with second trimester, P , 0.05) but no main effect of metabolic phase or BMI, and no interaction effects.
9 Measured for per kg body weight data only. Significant effect of metabolic phase (fasted compared with fed, P , 0.0001) and trimester (first compared with second trimester, P , 0.005) but no main effect of BMI. Significant interaction effect between metabolic phase and trimester (P , 0.005): leucine balance in the fed state was significantly lower in the first trimester than in the second trimester (P , 0.005); other 2-factor and 3-factor interactions were not significant. the first to the second trimesters and was not different between groups or metabolic states (Table 3) .
DISCUSSION
The results of this study showed a decrease in weight-specific leucine oxidation with increases in NOLD and leucine balance from the first to the second trimesters in both groups of women, which indicated that the extra amino acids required for increased maternal protein synthesis during pregnancy are provided by an overall decrease in amino acid catabolism in women with normal or low BMIs. Thus, our a priori hypothesis that the low-BMI group may not adapt to the requirements of pregnancy was rejected. Indeed, given their higher protein intake but similar flux rates, it is possible that the low-BMI group up-regulated protein turnover to a greater extent than did the normal-weight group in early pregnancy. We did not study nonpregnant women, because our specific aim was to determine whether there was a difference in amino acid kinetics between the BMI groups at similar times during pregnancy, assuming that the normal BMI women represented a control state.
In earlier studies in normal-weight pregnant women, lower urea production and excretion were reported (7-9) along with a progressive decrease in the proportion of dietary nitrogen converted to urea (8) . This, together with a similar decrease in leucine transamination and percentage leucine flux oxidized (7), suggest that the amino acids required for increased maternal protein synthesis are provided by an overall reduction in amino acid catabolism. Until now it was not known whether the underweight pregnant woman with a low BMI and body protein stores could also make these adaptations successfully. The present study corroborates similar findings by others (6) (7) (8) (9) 19) , indicating that the low-BMI group also provides the amino acids required for pregnancy by decreasing amino acid catabolism as pregnancy progressed, even though their leucine oxidation rates were significantly higher than those of the normal-BMI group. In both groups, this translated to a greater efficiency of utilization of dietary leucine for protein synthesis in the second trimester, as was found earlier (7, 8) . Whereas the efficiency tended to be lower in the low-BMI group, it was compensated for by their spontaneous consumption of 50% more dietary protein than the normal-BMI group in both trimesters ( Table 2) . It is therefore a distinct possibility that this relatively inefficient use of protein by the mothers with a low BMI could lead to lower lean tissue deposition as pregnancy progresses, if they do not have ready access to more food. It has been shown that maternal protein accretion occurs in early pregnancy, even before there is significant growth of the fetus (20, 21) . The correlation of both infant birth weight and GWG with leucine kinetic parameters such as oxidation, NOLD, and flux in the first but not the second trimester suggests that early changes in maternal protein metabolism are more critical for a successful pregnancy and are probably important predictors of pregnancy outcome. The women with a low BMI were also capable of producing alanine nitrogen at the same rate as in women with a normal BMI in both the first and second trimesters of pregnancy, whereas producing glutamine amide-nitrogen at a faster rate, in both the fed and fasted states, in the first trimester. The faster protein breakdown rate in the low-BMI group in the first trimester is a logical explanation for their faster glutamine amide-nitrogen flux at this time, which suggests that the availability of labile nitrogen to support the de novo synthesis of other dispensable amino acids was greater in this group of women early in pregnancy. Because alanine and glutamine are 2 primary providers of nitrogen for the de novo synthesis of dispensable amino acids (22, 23) , and because birth weight outcomes were similar between the groups, it is suggested that the women with a low BMI were producing sufficient quantities of labile nitrogen to support the syntheses of other dispensable amino acids necessary for the synthesis and deposition of new maternal and fetal tissues. In healthy men and women it has been reported that glutamine and alanine contribute carbon equally ('5% each) to the glucose produced in the fasted state (24) . Hence, the higher glutamine flux of the low-BMI group suggests an ample supply of proteinderived carbon to support gluconeogenesis, more so in the fasted state when it has been reported that 42% of glutamine carbon and 25% of alanine carbon are derived from amino acids released from protein breakdown (24) . This may explain our earlier finding (25) that gluconeogenesis and glucose production were similar in fasted pregnant women with low or normal BMI. Although it can be argued that we measured fluxes of alanine nitrogen and glutamine amide-nitrogen in the present study, evidence in the literature indicates that alanine and glutamine carbon fluxes are usually higher in fasted human subjects and that measured nitrogen fluxes were remarkably close to the values reported by others for fasted healthy subjects (22, 24, 26) . The glycine results in the low-BMI group were very similar to those of glutamine, which suggests that an adequate supply (compared with control subjects) was available in early pregnancy for this critical amino acid that is both a substrate for proteins and peptides. Glycine is also a precursor for biomolecules that are necessary for the laying down of new maternal and fetal tissues, particularly in later gestation, when, for example, most glycine-rich collagen is synthesized (27) . However, in the present study, glycine flux tended to decrease at the end of the second trimester in both groups in a fashion comparable with that in adolescent girls at risk of delivering LBW 1 All values are means 6 SDs. Fat-free mass (FFM)-specific kinetics are presented only for the first trimester, because this measurement was only made for the first trimester. Data were analyzed by using a mixed-model ANOVA.
2 Significant main effect of BMI (low BMI compared with normal BMI, P , 0.05), metabolic phase (fasted compared with fed, P , 0.0005), and trimester (first compared with second trimester, P , 0.05).
3 Significant main effect of metabolic phase (fasted compared with fed, P , 0.001) but no main effect of BMI. 4 Significant main effect of BMI (low BMI compared with normal BMI, P , 0.05) but no main effect of trimester. 5 Significant main effect of BMI (low BMI compared with normal BMI, P , 0.05) and trimester (first compared with second trimester, P , 0.05) but no main effect of metabolic state. 6 Significant main effect of metabolic phase (fasted compared with fed, P , 0.01) but no main effect of BMI.
infants, who have also been shown to have a lower glycine flux in later pregnancy than control subjects, in whom glycine flux tended to increase (28) . Cysteine flux was also higher in the low-BMI group, particularly in the second trimester; however, unlike glutamine and glycine, flux was lower in the fed state. This suggests that de novo cysteine synthesis was not sufficiently stimulated to sustain total flux when its release from protein breakdown was diminished. This may be due to the fact that cysteine, although it is categorized as a dispensable amino acid, has to receive its sulfur from the indispensable amino acid methionine during synthesis. Because of the marked reduction in protein breakdown in the fed state, a distinct possibility was that cysteine synthesis was not sufficiently increased to maintain total flux because of the insufficient availability of methionine.
Whereas a low maternal BMI and low GWG are thought to be the important determinants of LBW (1-4), our present finding of similar infant birth weights between the 2 groups indicates that women with a low BMI who have adequate access to energy and protein can adapt successfully to the demands of pregnancy. This could be for 2 reasons. First, all of the women in this study had access to optimal health care and good nutrition. Second, sufficient amino acids were available for the successful laying down of maternal reproductive tissues and early fetal protein accretion, particularly in the fasted state. The ability of the low-BMI group to have a net protein synthesis, positive balance, and weekly GWG similar to the normal-BMI group, despite a higher amino acid oxidation rate, suggests that they had sufficient amino acids to satisfy protein accretion, fetal energy utilization, and increased maternal gluconeogenesis. This latter finding may have important implications concerning the supplemental feeding of pregnant women with a low BMI early in pregnancy.
From these results we conclude that the extra amino acids and labile nitrogen needed for increased protein and de novo amino acid synthesis in pregnancy are obtained through a common mechanism of increased protein breakdown and decreased oxidation in both normal-weight and underweight women. The former was more marked in the women with a low BMI, who had higher protein intakes but a lower efficiency of utilization of dietary and endogenously produced leucine. These changes in protein and amino acid metabolism emphasize the importance of an early and adequate intake of dietary protein in pregnancy.
